Laser minimally invasive treatment for benign eyelid tumor dose to the lacrimal point
Jing ZHANG,Rong-xing QIU,Tian-yu ZHANG
DOI: https://doi.org/10.14166/j.issn.1671-2420.2018.03.015
2018-01-01
Abstract:Objective To evaluate the treatment of benign eyelid lesions close to the lacrimal point with a super pulse CO2 laser.Methods Prospective clinical study was used.Twenty-four patients who suffered from benign eyelid tumor close to the lacrimal point were treated with super pulse CO2 laser photocoagulation between January 2016 and February 2017.Before treatment,all patients received the usual clinical care,consisting of a case history and ophthalmological examinations including visual acuity,intraocular pressure,and a slit-lamp examination of the eyelids,anterior ocular segment,and syphilis of lacrimal passages.The age,sex,follow-up time,operated eye and eyelid,and the number of lesions were recorded,including any postoperative complications or recurrence.The follow-up time was 1 week,1 month,3 months and 6 months.Histological diagnoses were obtained in all patients.Results The cosmetic outcomes of all patients were satisfactory after treatment,and the wounds formed dry scabs,with no infections.They were epithelialized within 2 to 4 weeks with normal-appearing epithelium.The treated area showed no obvious scars or notches.All patients had intact tear spots and unobstructed lacrimal passages.No complications were observed,with no relapses during the follow-up.Conclusions The super pulse CO2 laser therapy of the benign eyelid tumors close to the lacrimal point provided satisfactory cosmetic results in this study.It is a convenient,cheap,accessible,and well-tolerated alternative to the traditional surgery,especially for those positioned close to the lacrimal papillae.